Post by Kymera Therapeutics

We’re looking forward to an impactful few days in Nashville at the Revolutionizing Atopic Dermatitis conference, where the dermatology community will come together to discuss unmet patient needs and emerging therapeutic approaches in atopic dermatitis. Stop by our exhibition table and poster presentation on KT-621, our investigational, first-in-class, oral STAT6 degrader, to learn more! #RAD2026 #RevolutionizingImmunology